Skip to main content
Erschienen in: International Urology and Nephrology 2/2014

01.02.2014 | Nephrology - Original Paper

Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention

verfasst von: Yuan Hui Liu, Yong Liu, Ning Tan, Ji-yan Chen, Jin Chen, Shao-hui Chen, Yi-ting He, Peng Ran, Piao Ye, Yun Li

Erschienen in: International Urology and Nephrology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Contrast-induced acute kidney injury (CI-AKI) is a well-known serious complication of percutaneous coronary intervention (PCI) and may cause increased morbidity and mortality. We aim to identify the predictive value of Global Registry for Acute Coronary Events (GRACE) risk scores for CI-AKI in patients with ST-segment elevation myocardial infarction (STEMI) before primary PCI, allowing pre-procedural decisions regarding prevention therapy for CI-AKI.

Methods

We enrolled 251 consecutive patients with STEMI undergoing primary PCI. Receiver operating characteristic curves were used to identify the optimal sensitivity for the observed range of GRACE risk scores. CI-AKI was defined as any of the following: absolute increase in serum creatinine (SCr) of ≥ 0.3 or ≥ 0.5 mg/dL within 48–72 h after contrast exposure, or a percentage increase in SCr level of ≥ 50 %.

Results

Forty-three patients (17.1 %) developed CI-AKI0.3, 22 (8.8 %) CI-AKI0.5, and 19 (7.6 %) CI-AKI50. The GRACE quartiles were as follows: Q1 (<136), Q2 (136–159), Q3 (159–180), and Q4 (>180). Patients with high GRACE risk scores had higher risk for CI-AKI0.3, 0.5, and 50 (6.6, 6.6, 23.4, 31.7 %, respectively, p < 0.001; 1.6, 1.6, 9.4, 22.2 %, respectively, p < 0.001; and 3.3, 3.2, 9.4, 14.3 %, respectively, p = 0.009). ROC showed that a GRACE risk score >160 was a fair discriminator for CI-AKI0.3, 0.5, and 50 (C statistic = 0.723, 0.788, 0.668, respectively). After adjusting for potential confounding predictors, GRACE risk score >160 remained significantly associated with CI-AKI0.3 or 0.5 (OR 3.84; 95 % CI 1.61–9.17; p = 0.002, or OR 5.54; 95 % CI 1.42–21.66; p = 0.014), and high-sensitivity C-reactive protein (Hs-CRP) >15.5 mg/L was a highly significant predictor of CI-AKI0.3, 0.5, and CI-AKI50.

Conclusions

GRACE risk score (>160) and post-procedural Hs-CRP >15.5 mg/L are independent and significant predictors of CI-AKI in patients with STEMI before primary PCI.
Literatur
1.
Zurück zum Zitat McCullough PA, Adam A, Becker CR et al (2006) Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98:5K–13KPubMedCrossRef McCullough PA, Adam A, Becker CR et al (2006) Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98:5K–13KPubMedCrossRef
2.
Zurück zum Zitat Wi J, Ko YG, Kim JS et al (2011) Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart 97:1753–1757PubMedCrossRef Wi J, Ko YG, Kim JS et al (2011) Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart 97:1753–1757PubMedCrossRef
3.
Zurück zum Zitat Marenzi G, Lauri G, Assanelli E et al (2004) Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44:1780–1785PubMedCrossRef Marenzi G, Lauri G, Assanelli E et al (2004) Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44:1780–1785PubMedCrossRef
4.
Zurück zum Zitat Cox CD, Tsikouris JP (2004) Preventing contrast nephropathy: what is the best strategy? A review of the literature. J Clin Pharmacol 44:327–337PubMedCrossRef Cox CD, Tsikouris JP (2004) Preventing contrast nephropathy: what is the best strategy? A review of the literature. J Clin Pharmacol 44:327–337PubMedCrossRef
5.
Zurück zum Zitat Mueller C, Buerkle G, Buettner HJ et al (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329–336PubMedCrossRef Mueller C, Buerkle G, Buettner HJ et al (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329–336PubMedCrossRef
6.
Zurück zum Zitat Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399PubMed Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399PubMed
7.
Zurück zum Zitat Eagle KA, Lim MJ, Dabbous OH et al (2004) A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291:2727–2733PubMedCrossRef Eagle KA, Lim MJ, Dabbous OH et al (2004) A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291:2727–2733PubMedCrossRef
8.
Zurück zum Zitat Pieper KS, Gore JM, FitzGerald G et al (2009) Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events. Am Heart J 157:1097–1105PubMedCrossRef Pieper KS, Gore JM, FitzGerald G et al (2009) Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events. Am Heart J 157:1097–1105PubMedCrossRef
9.
Zurück zum Zitat Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527–2541PubMedCrossRef Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527–2541PubMedCrossRef
10.
Zurück zum Zitat Senoo T, Motohiro M, Kamihata H et al (2010) Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 105:624–628PubMedCrossRef Senoo T, Motohiro M, Kamihata H et al (2010) Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 105:624–628PubMedCrossRef
11.
Zurück zum Zitat Kiyokuni M, Kosuge M, Ebina T et al (2012) Impact of the contrast-induced nephropathy definition on long-term outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circulation 126:A11578 Kiyokuni M, Kosuge M, Ebina T et al (2012) Impact of the contrast-induced nephropathy definition on long-term outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circulation 126:A11578
12.
Zurück zum Zitat Liu Y, Tan N, Zhou YL et al (2012) The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention. Int Urol Nephrol 44:221–229PubMedCrossRef Liu Y, Tan N, Zhou YL et al (2012) The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention. Int Urol Nephrol 44:221–229PubMedCrossRef
13.
Zurück zum Zitat Addala S, Grines CL, Dixon SR et al (2004) Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol 93:629–632PubMedCrossRef Addala S, Grines CL, Dixon SR et al (2004) Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol 93:629–632PubMedCrossRef
14.
Zurück zum Zitat Halkin A, Singh M, Nikolsky E et al (2005) Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45:1397–1405PubMedCrossRef Halkin A, Singh M, Nikolsky E et al (2005) Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45:1397–1405PubMedCrossRef
15.
Zurück zum Zitat Morrow DA, Antman EM, Charlesworth A et al (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102:2031–2037PubMedCrossRef Morrow DA, Antman EM, Charlesworth A et al (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102:2031–2037PubMedCrossRef
16.
Zurück zum Zitat De Luca G (2004) Suryapranata H, van T HA, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 109:2737–2743PubMedCrossRef De Luca G (2004) Suryapranata H, van T HA, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 109:2737–2743PubMedCrossRef
17.
Zurück zum Zitat O’Gara PT, Kushner FG, Ascheim DD et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:e78–e140PubMedCrossRef O’Gara PT, Kushner FG, Ascheim DD et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:e78–e140PubMedCrossRef
18.
Zurück zum Zitat Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264PubMedCrossRef Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264PubMedCrossRef
19.
Zurück zum Zitat Rosenstock JL, Gilles E, Geller AB et al (2010) Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease. Int Urol Nephrol 42:1049–1054PubMedCrossRef Rosenstock JL, Gilles E, Geller AB et al (2010) Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease. Int Urol Nephrol 42:1049–1054PubMedCrossRef
20.
Zurück zum Zitat Al SJ, Reddan DN, Williams K et al (2002) Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 106:974–980CrossRef Al SJ, Reddan DN, Williams K et al (2002) Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 106:974–980CrossRef
21.
Zurück zum Zitat Raposeiras-Roubin S, Aguiar-Souto P, Barreiro-Pardal C et al (2013) GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function. Angiology 64:31–39PubMedCrossRef Raposeiras-Roubin S, Aguiar-Souto P, Barreiro-Pardal C et al (2013) GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function. Angiology 64:31–39PubMedCrossRef
22.
Zurück zum Zitat Patti G, Ricottini E, Nusca A et al (2011) Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty–contrast-induced nephropathy] trial. Am J Cardiol 108:1–7PubMedCrossRef Patti G, Ricottini E, Nusca A et al (2011) Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty–contrast-induced nephropathy] trial. Am J Cardiol 108:1–7PubMedCrossRef
23.
Zurück zum Zitat Firouzi A, Eshraghi A, Shakerian F et al (2012) Efficacy of pentoxifylline in prevention of contrast-induced nephropathy in angioplasty patients. Int Urol Nephrol 44:1145–1149PubMedCrossRef Firouzi A, Eshraghi A, Shakerian F et al (2012) Efficacy of pentoxifylline in prevention of contrast-induced nephropathy in angioplasty patients. Int Urol Nephrol 44:1145–1149PubMedCrossRef
24.
Zurück zum Zitat Yavari V, Ostovan MA, Kojuri J et al (2013) The preventive effect of pentoxifylline on contrast-induced nephropathy: a randomized clinical trial. Int Urol Nephrol. doi:10.1007/s11255-013-0420-4 Yavari V, Ostovan MA, Kojuri J et al (2013) The preventive effect of pentoxifylline on contrast-induced nephropathy: a randomized clinical trial. Int Urol Nephrol. doi:10.​1007/​s11255-013-0420-4
25.
Zurück zum Zitat Miao Y, Zhong Y, Yan H et al (2013) Alprostadil plays a protective role in contrast-induced nephropathy in the elderly. Int Urol Nephrol 45:1179–1185PubMedCrossRef Miao Y, Zhong Y, Yan H et al (2013) Alprostadil plays a protective role in contrast-induced nephropathy in the elderly. Int Urol Nephrol 45:1179–1185PubMedCrossRef
26.
Zurück zum Zitat Marenzi G, Assanelli E, Marana I et al (2006) N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354:2773–2782PubMedCrossRef Marenzi G, Assanelli E, Marana I et al (2006) N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354:2773–2782PubMedCrossRef
27.
Zurück zum Zitat Wu MY, Hsiang HF, Wong CS et al (2013) The effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials. Int Urol Nephrol 45:1309–1318 Wu MY, Hsiang HF, Wong CS et al (2013) The effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials. Int Urol Nephrol 45:1309–1318
28.
Zurück zum Zitat Leone AM, De Caterina AR, Sciahbasi A et al (2012) Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (BIcarbonato e N-Acetil-cisteina nell’infaRto mIocardico acutO) study. EuroIntervention 8:839–847PubMedCrossRef Leone AM, De Caterina AR, Sciahbasi A et al (2012) Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (BIcarbonato e N-Acetil-cisteina nell’infaRto mIocardico acutO) study. EuroIntervention 8:839–847PubMedCrossRef
29.
Zurück zum Zitat Schwedler SB, Kuhlencordt PJ, Ponnuswamy PP et al (2007) Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen species. Atherosclerosis 195:e76–e84PubMedCrossRef Schwedler SB, Kuhlencordt PJ, Ponnuswamy PP et al (2007) Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen species. Atherosclerosis 195:e76–e84PubMedCrossRef
30.
Zurück zum Zitat Russo D, Minutolo R, Cianciaruso B et al (1995) Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 6:1451–1458PubMed Russo D, Minutolo R, Cianciaruso B et al (1995) Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 6:1451–1458PubMed
31.
Zurück zum Zitat Bakris GL, Lass NA, Glock D (1999) Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors. Kidney Int 56:206–210PubMedCrossRef Bakris GL, Lass NA, Glock D (1999) Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors. Kidney Int 56:206–210PubMedCrossRef
32.
Zurück zum Zitat Quintavalle C, Fiore D, De Micco F et al (2012) Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation 126:3008–3016PubMedCrossRef Quintavalle C, Fiore D, De Micco F et al (2012) Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation 126:3008–3016PubMedCrossRef
33.
Zurück zum Zitat Gao F, Zhou YJ, Zhu X et al (2011) C-reactive protein and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Am J Nephrol 34:203–210PubMedCrossRef Gao F, Zhou YJ, Zhu X et al (2011) C-reactive protein and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Am J Nephrol 34:203–210PubMedCrossRef
34.
Zurück zum Zitat Liu Y, Tan N, Zhou YL et al (2012) High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention. J Nephrol 25:332–340PubMedCrossRef Liu Y, Tan N, Zhou YL et al (2012) High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention. J Nephrol 25:332–340PubMedCrossRef
35.
Zurück zum Zitat Raposeiras-Roubin S, Barreiro PC, Rodino JB et al (2012) High-sensitivity C-reactive protein is a predictor of in-hospital cardiac events in acute myocardial infarction independently of GRACE risk score. Angiology 63:30–34PubMedCrossRef Raposeiras-Roubin S, Barreiro PC, Rodino JB et al (2012) High-sensitivity C-reactive protein is a predictor of in-hospital cardiac events in acute myocardial infarction independently of GRACE risk score. Angiology 63:30–34PubMedCrossRef
Metadaten
Titel
Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention
verfasst von
Yuan Hui Liu
Yong Liu
Ning Tan
Ji-yan Chen
Jin Chen
Shao-hui Chen
Yi-ting He
Peng Ran
Piao Ye
Yun Li
Publikationsdatum
01.02.2014
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2014
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0598-5

Weitere Artikel der Ausgabe 2/2014

International Urology and Nephrology 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.